FICORELLA, Corrado
 Distribuzione geografica
Continente #
NA - Nord America 7.015
EU - Europa 4.058
AS - Asia 1.838
OC - Oceania 10
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
Totale 12.943
Nazione #
US - Stati Uniti d'America 6.998
IE - Irlanda 1.512
CN - Cina 992
TR - Turchia 730
SE - Svezia 520
DE - Germania 476
UA - Ucraina 433
IT - Italia 412
GB - Regno Unito 315
FI - Finlandia 161
FR - Francia 121
IN - India 42
VN - Vietnam 37
BE - Belgio 36
RU - Federazione Russa 18
CA - Canada 12
AU - Australia 9
EU - Europa 8
RO - Romania 8
KR - Corea 7
BG - Bulgaria 6
IL - Israele 6
NL - Olanda 6
ES - Italia 5
RS - Serbia 5
JP - Giappone 4
TH - Thailandia 4
CH - Svizzera 3
ID - Indonesia 3
MX - Messico 3
PL - Polonia 3
PT - Portogallo 3
SG - Singapore 3
AR - Argentina 2
AT - Austria 2
BR - Brasile 2
CL - Cile 2
DM - Dominica 2
EE - Estonia 2
NO - Norvegia 2
ZA - Sudafrica 2
AM - Armenia 1
BF - Burkina Faso 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 12.943
Città #
Jacksonville 1.690
Chandler 1.624
Dublin 1.512
Izmir 360
Wilmington 293
Nanjing 279
Boardman 249
Princeton 241
Lawrence 240
Ann Arbor 236
San Mateo 226
New York 199
Ashburn 188
Beijing 134
Nanchang 98
Milan 88
Bremen 77
Seattle 76
Shenyang 64
Des Moines 59
Woodbridge 58
Dearborn 55
Tianjin 53
Verona 50
L'aquila 49
Hebei 44
Los Angeles 41
Brussels 36
Kunming 36
Dong Ket 34
Jiaxing 33
Jinan 31
Norwalk 30
Hangzhou 27
Zhengzhou 25
Philadelphia 24
Changsha 21
Mountain View 21
Pune 19
Aquila 17
Helsinki 17
Ningbo 17
Guangzhou 16
Falls Church 14
Auburn Hills 12
Fremont 12
London 12
Rome 12
Düsseldorf 11
Lanzhou 11
Redwood City 11
Taizhou 11
Changchun 10
Houston 10
Monza 10
Fuzhou 9
Hefei 9
L’Aquila 7
San Francisco 7
Tappahannock 7
Shanghai 6
Edinburgh 5
Frankfurt am Main 5
Sofia 5
Stockholm 5
Sydney 5
Grafing 4
Orange 4
Pescara 4
Washington 4
Caserta 3
Chengdu 3
Ciampino 3
Hanoi 3
Madrid 3
Qingdao 3
Seveso 3
Songkhla 3
Teramo 3
Toronto 3
Venezia 3
Zurich 3
Amsterdam 2
Atlanta 2
Baotou 2
Birmingham 2
Bucharest 2
Campobasso 2
Canberra 2
Castellucchio 2
Catanzaro 2
Cedar Knolls 2
Chieti 2
Columbia 2
Halifax 2
Istanbul 2
Kragujevac 2
Lappeenranta 2
Manchester 2
Messina 2
Totale 8.981
Nome #
Breast cancer and psychological resilience among young women 194
Emotional Impact of Breast Cancer Treatment: cross-sectional study on level of anxiety, anger, psychological distress and depression in 2-years perspective 119
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer 107
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 98
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 96
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 93
Efficacy of pregabalin in the management of cetuximab-related itch 91
Predictive Features of Resilience in Early Breast Cancer Young Patients: experience in Real Life 91
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 91
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 90
Dose-finding study of oxaliplatin associated to capecitabine based preoperative chemoradiotherapy in locally advanced rectal cancer 87
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 86
Does pain intensity predict a poor opioid response in cancer patients? 84
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 84
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 84
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 84
Assessment and treatment of symptoms among italian medical oncologists 80
The supportive care task force at the University of L'Aquila: 2-years experience 80
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 80
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 79
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 79
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 77
ABERRANT HYPERMETHYLATION OF THE P16 GENE IN SPORADIC GASTRIC CANCER 76
Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature 76
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 75
NEW MUTATIONS AND PROTEIC VARIANTS OF NBS1 ARE IDENTIFIED IN CANCER CELL LINES 74
Pain evaluation and management: a survey of Italian radiotherapists 74
Tapentadol in cancer pain management: a prospective open-label study 74
Palliative care in advanced cancer patients: how and when? And where? 73
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 73
Low morphine doses in opioid-naive cancer patients with pain 72
Colorectal cancer (Duke's group B2,C1,C2): adjuvant chemotherapy and toxicity 72
Psychological impact of clinical treatment after breast cancer diagnosis in younger patients (38–50 age range): An explorative 3-year observational study 72
Poker association of weekly alternating 5-fluorouracil, irinotecan,bevacizumab and oxaliplatin (FIrB/FOx) in first line treatment of metastatic colorectal cancer: a phase II study 71
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 71
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 71
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 71
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 70
Studies on chemically induced neoplastic transformation and mutation in the BALB/3T3 C1 A31-1-1 cell line in relation to the quantitative evaluation of carcinogens 69
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 69
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 69
Biological Function of Oncogenic KRAS In Promoting Angiogenesis 69
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice 69
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 69
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro 68
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer 68
Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer 68
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 68
Meccanismo d’azione e farmacologia di nuovi composti organometallici nel trattamento del carcinoma del colon-retto. 67
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 67
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 67
Treatment of hepatic metastases from colo-rectal tumors: intra-arterial loco-regional therapy 66
Multidisciplinary management of hepatocellular carcinoma in clinical practice 66
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 65
Novel P53 mutations detected by FAMA in colorectal cancers 65
Oncologia Clinica 65
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study 65
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 65
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 65
Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifene 64
The adjuvant therapy of colonic carcinoma in old age 64
Prognosis of gastric cancer by p53 gene mutations from "touch preparations" and PCR/SSCP analysis. 64
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. 64
Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer 64
Carcinoma of the breast in men 63
Morphine in the treatment of incident pain triggered by vinorelbine infusion 63
Familial ovarian cancer: a study of 11 families 63
Carcinoma della vescica 63
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 63
Low doses of transdermal fentanyl in opioid-naive patients with cancer pain 63
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 63
Valutazione farmacocinetica della perfusione pelvica ipossica nel trattamento di pazienti con recidiva non resecabile da carcinoma del retto. 63
Triplet Chemotherapy in Patients With Metastatic Colorectal Cancer: Toward the Best Way to Safely Administer a Highly Active Regimen in Clinical Practice 62
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients 62
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 62
Prognosis of gastric cancer by p53 gene mutations from "touch preparations" and PCR/SSCP analysis. 62
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 62
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study 62
Medical emergencies in oncology: hypercalcemia. II. Diagnosisand therapy 61
Clinical guidelines for the management of gastrointestinal stromal tumors 61
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 61
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 61
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 61
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen 61
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study 60
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama 60
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 60
Physical Exercise and Quality of Life in Breast Cancer Survivors 60
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, Fir-B/FOx, according to seconde-line treatment and KRAS genotype 60
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer 59
Intraperitoneal chemotherapy [LA CHEMIOTERAPIA INTRAPERITONEALE] 59
Familiarity and heredity of tumors in function of an early surgical therapeutic approach 59
Tamoxifen and breast cancer: is everything known already? 59
Oxaliplatin:preclinical in vitro studies 59
Carcinoma della pelvi renale e dell'uretere 59
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 59
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 58
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 58
Effectiveness of liver metastasectomies in Metastatic Colorectal Cancer (MCRC) patients treated with triplet chemotherapy plus bevacizumab (FIr-B/FOx) 58
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 58
Totale 7.135
Categoria #
all - tutte 48.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019513 0 0 0 0 0 0 0 0 0 0 34 479
2019/20201.772 312 42 186 15 8 213 392 43 249 52 10 250
2020/20211.957 39 248 10 250 244 57 254 25 281 64 384 101
2021/20221.337 57 116 223 68 62 24 27 91 85 33 106 445
2022/20234.592 316 300 71 495 447 474 4 300 1.954 21 126 84
2023/2024943 152 56 49 127 75 297 11 97 2 46 31 0
Totale 13.229